Skip to results
Modify your search
NARROW
1-5 of 5
Authors: Vijay Kunadian
Journal Article
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 66–74, https://doi.org/10.1093/ehjcvp/pvae080
Published: 17 October 2024
Journal Article
EDITOR'S CHOICE
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi.org/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article
EDITOR'S CHOICE
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi.org/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 328–336, https://doi.org/10.1093/ehjcvp/pvad006
Published: 17 January 2023
Journal Article
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 707–716, https://doi.org/10.1093/ehjcvp/pvac016
Published: 23 March 2022
